MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    A Case Report: Optimising Motor and Non-Motor Control in Advanced Parkinson’s Disease: The Role of Foslevodopa/Foscarbidopa After Deep Brain Stimulation

    J. Wong, S. Williams, M. Lubomski (St Leonards, Australia)

    Objective: To investigate the combined use of continuous subcutaneous foslevodopa/foscarbidopa and deep-brain stimulation in managing advanced Parkinsons Disease. Background: Continuous foslevodopa/foscarbidopa subcutaneous (SC) infusion has been shown…
  • 2026 International Congress

    Wearable-Derived Gait Biomarkers Predict Disease Severity and Quality of Life in Parkinson’s Disease: A Machine Learning and Mediation Analysis

    J. Jiang, W. Wang, W. Wei, L. Li, O. Ou, Z. Zhang, H. Hou, Y. Yang, X. Xiao, L. Lin, L. Liu, S. Shang (chengdu, China)

    Objective: To investigate whether wearable-derived gait biomarkers predict disease severity and health-related quality of life in Parkinson’s disease (PD) and to examine the mediating role…
  • 2026 International Congress

    Item – Level Drivers of Certification Failure in the MDS-UPDRS Motor Examination: A Five-Year Global Analysis

    C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

    Objective: To identify individual Part III items that disproportionately contribute to first-attempt certification failure and to evaluate the stability of these patterns over five years.…
  • 2026 International Congress

    Effect of subthalamic nucleus deep brain stimulation on heart rate variability in Parkinson’s disease

    CH. Sawanon, N. Limotai, N. Suanprasert, CH. Limotai, P. Sathirapanya, S. Rujirussawarawong (Bangkok, Thailand)

    Objective: To characterize the effects of bilateral subthalamic nucleus deep brain stimulation (STN-DBS) on cardiac autonomic regulation at rest and during paced deep breathing in advanced…
  • 2026 International Congress

    Digital Facial Movement Analysis in Hemifacial Spasm: Potential and Limitations as a Clinical Biomarker

    Z. Kosutzka, S. Sepelak, V. Hudzikova (Bratislava, Slovakia)

    Objective: To evaluate the potential use of digital biomarkers in the treatment assessment of hemifacial spasm (HFS) using botulinum toxin, also assessed with conventional methods…
  • 2026 International Congress

    The enteric footprint of de novo parkinson’s disease cohort: constipation, inflammation, and nulisa biomarker profiling.

    S. Enriquez Calzada, M. Miret Milian, L. Melgarejo, M. Arrué, A. López, S. Belmonte, M. Martinez-Vicente, J. Hernandez-Vara, A. Laguna (Barcelona, Spain)

    Objective: This study aimed to analyze constipation symptoms and blood, CSF and fecal biomarkers, including a High-plex Profiling of Inflammatory Proteins (NULISA) in a de novo PD cohort. Background: Parkinson’s disease…
  • 2026 International Congress

    Central Nervous System Lesioning Procedures For Dystonia In The Deep Brain Stimulation Era: A Systematic Review

    L. Santos, I. Lera, C. Ordás-Bandera, H. Canfield, A. Querejeta-Coma (Madrid, Spain)

    Objective: To evaluate the contemporary clinical role of central nervous system (CNS) lesioning procedures for dystonia in the deep brain stimulation (DBS) era, when DBS…
  • 2026 International Congress

    Systemic antioxidant response to bilateral anodal transcranial direct current stimulation in Parkinson’s disease: findings from a pilot randomized controlled study

    H. Hadoush, A. Al-Sharman, S. Banihani (Sharjah, United Arab Emirates)

    Objective: To investigate whether repeated sessions of bilateral anodal tDCS can influence circulating antioxidant enzyme levels and fatigue severity in individuals with Parkinson’s disease. Background:…
  • 2026 International Congress

    Regional landscape of Parkinson’s disease: An update from the NeuRA Natural History of Parkinson’s Study

    W. Liu, M. Li, R. Mackinnon, S. Geara, S. Lush, S. Rowe, C. Sue (Randwick, Australia)

    Objective: To characterise the epidemiology of Parkinson's Disease(PD) and compare risk factors/exposures between Regional and Metropolitan New South Wales(NSW). Background: The Natural History of PD…
  • 2026 International Congress

    Nation-wide Slovak epidemiological study of movement disorders in Roma population: protocol and initial results

    M. Skorvanek, A. Belak, J. Necpal, M. Ferenc, M. Giertlova, L. Gurcik, V. Han, S. Jaselska, G. Kalafusova, M. Krauz, K. Kulcsarova, A. Lackova, J. Mankos, Z. Matiskova, S. Orkuty, M. Ostrozovicova, J. Papikova, O. Shabatiuk, L. Trckova, D. Fricova (Kosice, Slovakia)

    Objective: To determine the prevalence and spectrum of movement disorders (MDs) in a nationwide Roma population–based screening. Background: Roma represent one of the least studied…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley